News Peg. Nirsevimab, Sanofi and AstraZeneca’s RSV shot for infants received unanimous backing from an advisory committee to the CDC on August 3. This comes almost two months after an FDA ...

RSV infections of the lungs and airways send up to 160,000 older adults to the hospital each year, at an annual cost of more than $1.3 billion, according to the Michigan Medicine report.

A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...

A new UK study shows that vaccinating pregnant women against RSV has led to a staggering 72% drop in hospitalizations of ...

Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, ...

A Canadian study highlights the elevated risks of heart failure and arrhythmia in older adults hospitalized for RSV, even ...

In older adults, respiratory syncytial virus (RSV) is associated with an increased risk for cardiovascular outcome, especially heart failure events.

We may use terms like cold and the flu as if they are the same thing, but there are some key differences between them.

Parental trust in clinicians drove RSV vaccine uptake, while confusion and limited access to reliable information hindered ...

“Our findings reinforce the importance of RSV vaccination in older adults and suggest that monitoring for signs of heart ...

Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being dangerous to babies and toddlers due to how often child-related ...

An RSV vaccine has been available to pregnant women in Northern Ireland since last September and is offered from 28 weeks of ...